{"organizations": [], "uuid": "ef65bfd766b3e1011234c0320d8eb8930a9a46b2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/brief-txcell-names-lonza-as-its-car-treg/brief-txcell-names-lonza-as-its-car-treg-cellular-product-manufacturer-idUSFWN1T20V9", "country": "US", "domain_rank": 408, "title": "BRIEF-Txcell Names Lonza As Its Car-Treg Cellular Product Manufacturer", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-31T23:53:00.000+03:00", "replies_count": 0, "uuid": "ef65bfd766b3e1011234c0320d8eb8930a9a46b2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-txcell-names-lonza-as-its-car-treg/brief-txcell-names-lonza-as-its-car-treg-cellular-product-manufacturer-idUSFWN1T20V9", "ord_in_thread": 0, "title": "BRIEF-Txcell Names Lonza As Its Car-Treg Cellular Product Manufacturer", "locations": [], "entities": {"persons": [{"name": "txcell", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "lonza", "sentiment": "negative"}, {"name": "onza pharma & biotech", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 31 (Reuters) - TXCELL SA:\n* TXCELL NAMES LONZA AS ITS CAR-TREG CELLULAR PRODUCT MANUFACTURER\n* LONZA PHARMA & BIOTECH TO MANUFACTURE CLINICAL BATCHES OF TXCELL’S HLA-A2 CAR-TREG CELLULAR PRODUCT FROM ITS PRODUCTION SITE IN GELEEN\n* MASTER SERVICE AGREEMENT SIGNED BETWEEN LONZA PHARMA & BIOTECH AND TXCELL FOR MANUFACTURE OF TXCELL’S HLA-A2 CAR-TREG CELLULAR PRODUCT Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-31T23:53:00.000+03:00", "crawled": "2018-05-31T21:13:23.003+03:00", "highlightTitle": ""}